Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Francesco Oddone. (2022) Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open-angle glaucoma and ocular hypertension management: a focus on efficacy, safety, and tolerability. Expert Opinion on Drug Safety 21:10, pages 1259-1268.
Read now
Read now
Anastasios G. Konstas, Leopold Schmetterer, Vital P. Costa, Gábor Holló, Andreas Katsanos, Philippe Denis, Luciano Quaranta, Murat Irkec, Miguel A. Castejón, Miguel A. Teus & Alan L. Robin. (2020) Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review. Expert Opinion on Drug Safety 19:11, pages 1445-1460.
Read now
Read now
Hideaki Okumichi, Yoshiaki Kiuchi, Tetsuya Baba, Takashi Kanamoto, Tomoko Naito, Shunsuke Nakakura, Hitoshi Tabuchi, Hiroki Nii, Chie Sueoka & Yosuke Sugimoto. (2017) The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study. Clinical Ophthalmology 11, pages 1175-1181.
Read now
Read now
Anastasios G. P. Konstas & Gabor Holló. (2016) Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma. Expert Opinion on Pharmacotherapy 17:9, pages 1271-1283.
Read now
Read now
María de los Angeles Ramos-Cadena & George L. Spaeth. (2016) Ocular surface disease and glaucoma. Expert Review of Ophthalmology 11:3, pages 215-226.
Read now
Read now
Articles from other publishers (9)
J. Esquena-Moret. (2022) A Review of Xyloglucan: Self-Aggregation, Hydrogel Formation, Mucoadhesion and Uses in Medical Devices. Macromol 2:4, pages 562-590.
Crossref
Crossref
I.B. Alekseev, A.V. Volkova & L.I. Alekseeva. (2022) Xalacom: possibilities and advantages of the drug in the treatment of patients with glaucoma. Vestnik oftal'mologii 138:5, pages 119.
Crossref
Crossref
Magdalena Gumińska, Roman Goś, Janusz Śmigielski & Michał S. Nowak. (2020) Topical Treatment of Elevated Intraocular Pressure in Patients with Graves’ Orbitopathy. International Journal of Environmental Research and Public Health 17:24, pages 9331.
Crossref
Crossref
Florent Aptel, Norbert Pfeiffer, Stefanie Schmickler, Jonathan Clarke, Cosme Lavín-Dapena, Javier Moreno-Montañés, Tomasz Żarnowski, Adrienne Csutak, Tiia Jugaste, Lāsma Volksone, Yury S. Astakhov, Laurent Coupier, Jean-Philippe Nordmann & Ingeborg Stalmans. (2019) Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension. Journal of Glaucoma 28:6, pages 498-506.
Crossref
Crossref
Kazuyo SadamotoShingo NemotoAkio KawamuraMasaaki Kurata. (2019) Comparison of cytotoxicity between fixed- and unfixed-combination ophthalmic solutions <i>in vitro</i>. Fundamental Toxicological Sciences 6:7, pages 245-248.
Crossref
Crossref
S. Lazreg, Z. Merad, M.T. Nouri, R. Garout, A. Derdour, N. Ghroud, R. Kherroubi, M. Meziane, S. Belkacem, O. Ouhadj, C. Baudouin & M. Tiar. (2018) Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications. Journal Français d'Ophtalmologie 41:10, pages 945-954.
Crossref
Crossref
Susan Yee. (2017) Glaucoma Theraphy: Finding the Right Combination. Highlights of Ophthalmology 45:2ENG, pages 6-10.
Crossref
Crossref
D.B. Hoover. 2016. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Fernando Pérez-Roca, Esther Rodrigo-Morales, Ingrid Garzón, Ana-Celeste Oliveira, Miguel-Ángel Martín-Piedra, Víctor Carriel, Ana-Isabel Ortiz-Pérez, Indalecio Sánchez-Montesinos, Antonio Campos & Miguel Alaminos. (2015) Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study. PLOS ONE 10:6, pages e0129419.
Crossref
Crossref